Adenosine 3',5'-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization

Endocrinology. 1983 May;112(5):1801-7. doi: 10.1210/endo-112-5-1801.

Abstract

Calcium (Ca2+) ionophore A23187 increased the intracellular cAMP content and PRL release in normal rat anterior pituitary cells. Cotreatment with dopamine reduced both control and A23187-stimulated cAMP accumulation and PRL release. The dopamine antagonist spiperone restored the response of cAMP to ionophoric stimulation after pretreatment with dopamine in the greatest concentration used. Penfluridol, a compound with Ca2+-calmodulin-blocking properties, decreased control and A23187-stimulated cAMP content and PRL release. W7, a selective calmodulin-blocking agent, reduced basal cAMP and PRL release, whereas W5, a W7 analog with only 20% of its calmodulin-blocking ability, did not affect cAMP or PRL secretion. These data indicate that the Ca2+-calmodulin and cAMP systems are interrelated in the regulation of PRL secretion. They are also consistent with the hypothesis that the inhibition of PRL release by dopamine occurs after Ca2+ is mobilized and when or before it stimulates adenylate cyclase activity.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Calcimycin / pharmacology
  • Calcium / metabolism*
  • Calcium-Binding Proteins / metabolism*
  • Calmodulin / metabolism*
  • Cells, Cultured
  • Cyclic AMP / metabolism*
  • Dopamine / pharmacology*
  • Kinetics
  • Male
  • Penfluridol / pharmacology
  • Pituitary Gland, Anterior / drug effects
  • Pituitary Gland, Anterior / metabolism
  • Pituitary Gland, Anterior / physiology*
  • Prolactin / metabolism*
  • Rats
  • Rats, Inbred Strains
  • Spiperone / pharmacology

Substances

  • Calcium-Binding Proteins
  • Calmodulin
  • Penfluridol
  • Calcimycin
  • Spiperone
  • Prolactin
  • Cyclic AMP
  • Calcium
  • Dopamine